These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 17823882

  • 21. Current strategies in the management of hypereosinophilic syndrome, including mepolizumab.
    Schwartz LB, Sheikh J, Singh A.
    Curr Med Res Opin; 2010 Aug; 26(8):1933-46. PubMed ID: 20565230
    [Abstract] [Full Text] [Related]

  • 22. Cessation of imatinib mesylate may lead to sustained hematologic and molecular remission in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome.
    Helbig G, Kyrcz-Krzemień S.
    Am J Hematol; 2014 Jan; 89(1):115. PubMed ID: 24009127
    [No Abstract] [Full Text] [Related]

  • 23. Murine model of hypereosinophilic syndromes/chronic eosinophilic leukemia.
    Yamada Y, Cancelas JA, Rothenberg ME.
    Int Arch Allergy Immunol; 2009 Jan; 149 Suppl 1():102-7. PubMed ID: 19494514
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.
    Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, Kutok J, Clark J, Galinsky I, Griffin JD, Cross NC, Tefferi A, Malone J, Alam R, Schrier SL, Schmid J, Rose M, Vandenberghe P, Verhoef G, Boogaerts M, Wlodarska I, Kantarjian H, Marynen P, Coutre SE, Stone R, Gilliland DG.
    N Engl J Med; 2003 Mar 27; 348(13):1201-14. PubMed ID: 12660384
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Durable efficacity and remission after treatment with imatinib mesylate for FIP1L1-PDGFRA transcript negative associated eosinophilic cardiomyopathy].
    Sekkach Y, Mekouar F, Jira M, Elqatni M, Elomri N, Fatihi J, Badaoui M, Hammi S, Smaali J, El Khattabi A, Amezyane T, Abouzahir A, Ghafir D.
    Ann Pharm Fr; 2011 Sep 27; 69(5):277-81. PubMed ID: 21924129
    [Abstract] [Full Text] [Related]

  • 30. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
    Gotlib J.
    Am J Hematol; 2014 Mar 27; 89(3):325-37. PubMed ID: 24577808
    [Abstract] [Full Text] [Related]

  • 31. [New insights into hypereosinophilic syndromes].
    Bletry O, Kahn JE, Ackermann F, Charles P, Legrand F.
    Bull Acad Natl Med; 2010 Mar 27; 194(3):547-59; discussion 559-60. PubMed ID: 21171248
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The hypereosinophilic syndrome: idiopathic or not, that is the question.
    Cools J.
    Haematologica; 2005 May 27; 90(5):582-4. PubMed ID: 15921372
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II study.
    Metzgeroth G, Walz C, Erben P, Popp H, Schmitt-Graeff A, Haferlach C, Fabarius A, Schnittger S, Grimwade D, Cross NC, Hehlmann R, Hochhaus A, Reiter A.
    Br J Haematol; 2008 Dec 27; 143(5):707-15. PubMed ID: 18950453
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Treatment of hypereosinophilic syndromes--the first 100 years.
    Butterfield JH, Weiler CR.
    Semin Hematol; 2012 Apr 27; 49(2):182-91. PubMed ID: 22449628
    [Abstract] [Full Text] [Related]

  • 40. Cell clonality in hypereosinophilic syndrome: what pathogenetic role?
    Galimberti S, Ciabatti E, Ottimo F, Rossi A, Trombi L, Carulli G, Cervetti G, Matti L, Bianchi G, Petrini M.
    Clin Exp Rheumatol; 2007 Apr 27; 25(1):17-22. PubMed ID: 17417985
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.